Lv3
210 积分 2024-10-25 加入
Sorafenib (BAY 43‐9006, Nexavar®), a Dual‐Action Inhibitor That Targets RAF/MEK/ERK Pathway in Tumor Cells and Tyrosine Kinases VEGFR/PDGFR in Tumor Vasculature
27天前
已完结
Inhibition of heat shock protein 90 exerts an antitumour effect in angiosarcoma: involvement of the vascular endothelial growth factor signalling pathway
29天前
已完结
The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer
29天前
已完结
Activated c‐Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer
4个月前
已完结
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
6个月前
已完结
Gastric Cancer Epidemiology
6个月前
已完结